TG Therapeutics, Inc. Announces Second Quarter 2015 Financial Results and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Strong earthquake rocks north-central Venezuela, capital Caracas
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
H.C. Wainwright Resumes TG Therapeutics (TGTX) at Buy
August 12, 2015 7:24 AM EDTH.C. Wainwright resumed coverage on TG Therapeutics (NASDAQ: TGTX) with a Buy rating and a price target of $22.00.
For an analyst ratings summary and ratings history on TG Therapeutics click here. For more ratings news on TG Therapeutics click here.
Shares of TG Therapeutics closed at $16.11 yesterday.
... MoreTG Therapeutics (TGTX) Misses Q2 EPS by 8c
August 10, 2015 9:14 AM EDTTG Therapeutics (NASDAQ: TGTX) reported Q2 EPS of ($0.38), $0.08 worse than the analyst estimate of ($0.30).
For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.
... More